DS
Dhaval Shah
About Dhaval Shah
Data last updated:
Dhaval Shah is a Whole-Time Director at Api Holdings Limited (since 2024), Director at Thyrocare Technologies Limited (since 2021) and Director at Docon Technologies Private Limited (since 2023), and holds 5 more current directorships. The companies operate in Healthcare, Real Estate and Consumer Services. The 6 current companies with reported revenue have a combined latest revenue of ₹7,638 Cr; the largest is Api Holdings Limited at ₹6,689 Cr (FY 2026). Earlier, Dhaval Shah was a Director at Digi Bharat Platform Ventures Private Limited (2024–2025) and Designated Partner at Hadd Consultancy Services Llp (2023–2025) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 15 May 2024 | 2019 | ₹6,689 Cr (FY 2026) | Active | |
| Director | 06 Oct 2021 | 2000 | ₹702 Cr (FY 2025) | Active | |
| Director | 31 Jan 2023 | 2016 | ₹196 Cr (FY 2025) | Active | |
| Director | 06 Oct 2021 | 2011 | ₹49.49 Cr (FY 2026) | Active | |
| Director | 26 Jun 2024 | 2024 | ₹80.1 Lakh (FY 2025) | Active | |
| Director | 29 Nov 2024 | 2024 | ₹10.2 Lakh (FY 2025) | Active | |
| Director | 28 Dec 2024 | 2024 | Active | ||
| Designated Partner | 17 Jun 2024 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Oct 2024 | 2024 | Active | ||
| Designated Partner | 16 Oct 2023 | 2023 | Active | ||
| Director | 28 Mar 2016 | 2014 | ₹364 Cr (FY 2019) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Dhaval Shah
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dhaval Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dhaval Shah
Dhaval Shah currently holds 8 directorships: Api Holdings Limited (Whole-Time Director, since 15 May 2024, revenue ₹6,689 Cr (FY 2026)); Thyrocare Technologies Limited (Director, since 06 Oct 2021, revenue ₹702 Cr (FY 2025)); Docon Technologies Private Limited (Director, since 31 Jan 2023, revenue ₹196 Cr (FY 2025)); Nueclear Healthcare Limited (Director, since 06 Oct 2021, revenue ₹49.49 Cr (FY 2026)); Drs Shah Advisors Private Limited (Director, since 26 Jun 2024, revenue ₹80.1 Lakh (FY 2025)); and 3 more.
Dhaval Shah was first appointed on 28 Mar 2016 as Director at 91Streets Media Technologies Private Limited. The most recent appointment on record is 28 Dec 2024 at Emergent Bharat Finance Private Limited.
The 6 current companies of Dhaval Shah that report revenue have a combined latest revenue of ₹7,638 Cr: Api Holdings Limited ₹6,689 Cr (FY 2026); Thyrocare Technologies Limited ₹702 Cr (FY 2025); Docon Technologies Private Limited ₹196 Cr (FY 2025); Nueclear Healthcare Limited ₹49.49 Cr (FY 2026); Drs Shah Advisors Private Limited ₹80.1 Lakh (FY 2025); and 1 more.
Dhaval Shah held 3 earlier board appointments: Digi Bharat Platform Ventures Private Limited (Director, 17 Oct 2024 to 06 Nov 2025); Hadd Consultancy Services Llp (Designated Partner, 16 Oct 2023 to 28 Oct 2025); 91Streets Media Technologies Private Limited (Director, from 28 Mar 2016).
The current boards of Dhaval Shah's companies include Aditya Puri (Api Holdings Limited), Alok Kumar Jagnani (Api Holdings Limited), Alok Kumar Jagnani (Api Holdings Limited), Archana Bhaskar (Api Holdings Limited), Ashutosh Sharma (Api Holdings Limited), Bobby Kanubhai Parikh (Api Holdings Limited), among others.